B Styk
About
In The Last Decade
B Styk
59 papers receiving 292 citations
Peers
Comparison fields: 5 of 41
- Epidemiology 256
- Molecular Biology 82
- Radiology, Nuclear Medicine and Imaging 78
- Infectious Diseases 60
- Immunology 54
Countries citing papers authored by B Styk
This map shows the geographic impact of B Styk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Styk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Styk more than expected).
Fields of papers citing papers by B Styk
This network shows the impact of papers produced by B Styk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Styk. The network helps show where B Styk may publish in the future.
Co-authorship network of co-authors of B Styk
This figure shows the co-authorship network connecting the top 25 collaborators of B Styk. A scholar is included among the top collaborators of B Styk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Styk. B Styk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 12 | |
| 2 | Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. III. Reactivity with human convalescent sera. | 18 |
| 3 | Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. IV. Immunogenic properties of separated haemagglutinin glycopolypeptides. | 10 |
| 4 | Antigenic glycopolypeptides HA1 and HA2 of influenza virus haemagglutinin. I. Gel filtration in 6 M guanidine hydrochloride. | 3 |
| 5 | Radioimmunoassay of influenza A virus haemagglutinin. I. Preparation and properties of radioactive 125I-labelled bromelain-released haemagglutinin. | 11 |
| 6 | A competitive-inhibition radioimmunoassay for influenza virus envelope antigens. | 5 |
| 7 | Steric effects in the reaction of influenza virus neuraminidases with antibodies. | 23 |
| 8 | 8 | |
| 9 | Rapid Diagnosis of Influenza by the Fluorescent Antibody Method. | 4 |
| 10 | Cofactor and Specific Antibodies against Influenza Viruses. VII. The Nature of Cofacto r and Influenza Antibodies studied by Density Gradient Zonal Centrifugation. | 4 |
| 11 | Effect of some Inhibitor-Destroying Substances on the Nonspecific Inhibitor of C Influenza Virus present in Normal Rat Serum. | 11 |
| 12 | [USE OF THE FLUORESCENT ANTIBODY TECHNIC FOR THE RAPID DIAGNOSIS OF INFLUENZA IN THE COURSE OF AN EPIDEMIC]. | 1 |
| 13 | Characterization of antibodies, cofactor and nonspecific viral inhibitors on Sephadex G-200. | 4 |
| 14 | Course of Adaptation of the Inhibitor-Resistant Influenza Virus A2 to Ferrets. | 2 |
| 15 | The Relation of Properdin and Complement to the Thermo-labile Cofactor of Normal Serum necessary for the Reaction of Specific Antibody with Influenza A2 Virus. | 2 |
| 16 | The Effect of Inhibitor-Destroying Substances on the Cofactor and Specific Antihaemagglutinins against A2 Influenza Virus. | 1 |
| 17 | Lipoids as Inhibitors of Haemagglutination-Inhibiting Activity against " Avid " Strains of A2 Influenza. | 3 |
| 18 | Investigations into Specific Antibodies against A2 Influenza Viruses and the Thermolabile Co-factor by means of Paper Electrophoresis. | 3 |
| 19 | Estimation of the Distribution and the Character of Inhibitors against "Avid" A2 Influenza Virus Strains in Protein Fractions of Guinea Pig and Horse Sera obtained by Paper Electrophoresis. | 3 |
| 20 | Non-Specific Inhibitors in Normal Rat Serum for the Influenza C Type Virus. The Relation between the Influenza C Type Virus, Newcastle Disease and Epidemic Parotitis. | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.